27 November 2015 - J. Kyle Bass made a fortune in the financial crisis when his hedge fund, Hayman Capital Management, bet big against subprime mortgages. Now Mr. Bass is wagering against pharmaceutical companies that he says exploit the patent system, keeping drug prices — and their profits — in the stratosphere.

For more details, go to: http://www.nytimes.com/2015/11/29/business/working-to-lower-drug-costs-by-challenging-questionable-patents.html?emc=edit_th_20151129&nl=todaysheadlines&nlid=20088616&_r=0